Figure 4. Results from fecal calprotectin testing among patients with irritable bowel diseases. T1, mild inflammation; T2, moderate inflammation; and T3, severe inflammation. The results are expressed as the number of patients; and the rate from 20 patients with inflammatory bowel diseases.